Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies
Karin Hellner(University of Oxford), Ahmed A. Ahmed(St. George's University)
Cited by 61
Related Papers
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation
|Nature Communications|2018|58
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells
|JCI Insight|2021|42
LARP1 regulates metabolism and mTORC1 activity in cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2022|1